miRNEST 2.0: an integrative microRNA resource miRNEST 2.0, an integrative microRNA resource :: Browse



Data derived from PhenomiR


PubMed IDdiseasedisease classtissueexpressionfoldchange maxfoldchange mingenesstudy designmethod
17473300 Gastrointestinal - 0 (Pancreatitis - 0) Gastrointestinal pancreas miRNA overexpression - 1.93 - Patient study phenotype-control miRNA microarray
17363563 Glioblastoma multiforme, somatic - 137800 Cancer U-251 cell miRNA downregulation - 83.6 - Cell culture study quantitative PCR
18042587 Systemic lupus erythematosus, susceptibility - 152700 Immunological blood miRNA downregulation - 4.88 - Patient study phenotype-control miRNA microarray
18042587 Thrombocytopenic purpurea, autoimmune - 188030 Hematological blood miRNA downregulation - 5.57 - Patient study phenotype-control miRNA microarray
18308931 Leukemia, acute myeloid - 601626 Cancer bone marrow miRNA downregulation - 1.92 - Patient study phenotype-phenotype quantitative PCR
18973228 Medulloblastoma - 155255 Cancer cerebellum miRNA downregulation - 100.0 - Patient study phenotype-control quantitative PCR
16192569 Breast cancer - 114480 Cancer T-47D cell miRNA downregulation - 4.54545 - Cell culture study quantitative PCR
16192569 Breast cancer - 114480 Cancer SK-BR-3 cell miRNA downregulation - 14.2857 - Cell culture study quantitative PCR
16754881 Ovarian cancer - 604370 Cancer ovary miRNA downregulation - - - Patient study phenotype-control array CGH
16754881 Breast cancer - 114480 Cancer breast epithelium miRNA downregulation - - - Patient study phenotype-control array CGH
16754881 Melanoma and neural system tumor syndrome - 155755 Cancer cell culture miRNA downregulation - - - Cell culture study array CGH
16192569 Breast cancer - 114480 Cancer MCF-7 cell miRNA downregulation - 2.5 - Cell culture study quantitative PCR
16192569 Breast cancer - 114480 Cancer MDA-MB-231 cell miRNA downregulation - 3.84615 - Cell culture study quantitative PCR
16192569 Breast cancer - 114480 Cancer MDA-MB-361 cell miRNA downregulation - 8.33333 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer PC-3 cell miRNA downregulation - 12.5 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer PPC-1 cell miRNA downregulation - 10.0 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer DU-145 cell miRNA downregulation - 33.3333 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer Tsu-Pr1 cell miRNA downregulation - 3.22581 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer LNCaP cell miRNA downregulation - 4.54545 - Cell culture study quantitative PCR
16192569 Squamous cell carcinoma, head and neck - 601400 Cancer squamous cell carcinoma cell line miRNA downregulation - 25.0 - Cell culture study quantitative PCR
16192569 Squamous cell carcinoma, head and neck - 601400 Cancer squamous cell carcinoma cell line miRNA downregulation - 9.09091 - Cell culture study quantitative PCR
19010882 Glioblastoma multiforme, somatic - 137800 Cancer brain miRNA overexpression - 4.53 - Patient study phenotype-control miRNA microarray
16192569 Pancreatic cancer - 260350 Cancer PANC-1 cell miRNA downregulation - 1.2987 - Cell culture study quantitative PCR
16192569 Lung cancer - 211980 Cancer lung cancer cell line miRNA downregulation - 5.0 - Cell culture study quantitative PCR
16192569 Hematological - 0 Hematological K-562 cell miRNA overexpression - 1.07 - Cell culture study quantitative PCR
16192569 Lung cancer - 211980 Cancer A-549 cell miRNA downregulation - 2.7027 - Cell culture study quantitative PCR